Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition

Area of Science:

• Endocrinology
• Cardiovascular Health
• Women's Health

Background:

• Metabolic risks are known in young women with irregular menses and androgen excess.
• The persistence of these risks after menopause remains unclear.

Purpose of the Study:

• To determine the impact of menopause on cardiometabolic profiles in women with a history of high androgens and menstrual irregularity.
• To investigate if prior hyperandrogenemia and oligomenorrhea predict long-term metabolic syndrome incidence post-menopause.

Main Methods:

• Longitudinal cohort study analyzing data from 1929 women without metabolic syndrome at baseline.
• Assessed incidence of metabolic syndrome, stroke, and myocardial infarction over 12 years.
• Used Cox hazard ratios adjusted for covariates including menopausal status and lifestyle factors.

Main Results:

• No significant difference in metabolic syndrome incidence was observed between women with a history of hyperandrogenemia/oligomenorrhea and controls.
• Smoking and obesity were identified as the strongest predictors of incident metabolic syndrome.
• No significant difference in stroke or myocardial infarction incidence was found based on hyperandrogenemia/oligomenorrhea status.

Conclusions:

• A history of androgen excess and menstrual irregularity is not associated with worsening metabolic health after menopause.
• Findings challenge the assumption that concurrent hyperandrogenemia and oligomenorrhea indicate ongoing cardiometabolic risk in postmenopausal women.